Publicly Traded Cannabis Stock News

Mettrum Sales Expand by 18% as Losses Narrow

Mettrum Announces Third Quarter Fiscal 2016 Financial Results Q3 2016 versus Q2 Financial Highlights: Revenue increased 18% to $2,016,683 Gross Margin increased 39% to $1,351,287 (67% of Sales) Reduced...
- February 23rd, 2016 at 6:28 pm

Canadian Cannabis Producer Aphria Sees Growth Ahead

Windsor Star reporter Doug Schmidt visited the Aphria (TSXV: APH) facility in Leamington, Ontario. His article, which includes a video interview with CEO Vic Neufeld, discusses the recent Health Canada approval for...
- February 22nd, 2016 at 7:50 pm

Health Canada Grants Two Cannabis Cultivation Licenses

Health Canada’s website today reflects the granting of two new licenses to cultivate medical cannabis. Green Relief, based in Ontario, and THC Biomed (CSE:THC) (OTC:THCBF), based in British Columbia, received the 28th...
- February 19th, 2016 at 3:42 pm

CV Sciences Responds to Cannabidiol FDA Warnings

Earlier today, the Food & Drug Administration (FDA) posted 8 warning letters issued to marketers of products containing cannabidiol (CBD).  Two of the companies receiving the letters were criticized for claims...
- February 10th, 2016 at 8:43 pm

Noted Cannabis Investor Shares Strategy on CNBC

CNBC interviewed Leslie Bocskor of Electrum Partners and included the video in a broader article about the cannabis industry.  Bocskor said that the legal cannabis industry, including hemp, could...
- February 3rd, 2016 at 11:38 am

Aurora Cannabis to Introduce 25% CBD Strain in February

Aurora Continues Accelerated Growth VANCOUVER, BRITISH COLUMBIA–(Marketwired – Feb. 2, 2016) – Aurora Cannabis Inc. (“Aurora” or the “Company”) (CSE:ACB)(OTCQB:ACBFF)(FRANKFURT:21P) (WKN: A1C4WM) is pleased to announce that its wholly-owned...
- February 2nd, 2016 at 1:02 pm

GW Pharma Phase 3 Data Due Soon

The Financial Times shared a great history of the ups and downs  of GW Pharma (NASDAQ: GWPH), which will soon report the results of the first of four Phase...
- February 1st, 2016 at 9:42 am

OrganiGram Q1 Sales Break $1mm and Grow 52% from Prior Quarter

OrganiGram: Q1 Financials and Director Appointment MONCTON, NEW BRUNSWICK–(Marketwired – Jan. 29, 2016) – OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) is pleased to announce its financial results for the three...
- January 29th, 2016 at 4:36 pm

Mettrum Second to Market with Cannabis Oils

Mettrum Health Corp. Launches Premium Cannabis Oils Product Line Variety of THC and CBD oils addresses demand for alternative cannabis consumption options TORONTO, Jan. 26, 2016 /CNW/ – Mettrum Health...
- January 26th, 2016 at 3:04 pm